Montu, its founder and managing director Christopher Strauch and the Therapeutic Goods Administration are due back in Victoria Federal Court on June 1 after a further case management hearing was adjourned.
The TGA filed legal action in April 2024 accusing Montu’s clinic, Alternaleaf, and Strauch of unlawfully advertising medicinal cannabis.
Lawyers for Montu and Strauch are due to file any expert evidence on the question liability by May 29, with TGA given three weeks to respond.
The court has previously set aside seven days for a trial.
Vitura Health
Vitura Health non-executive director and chair of its Industry Advisory Group, Gerard Fogarty, has resigned with immediate effect.
Fogarty joined the board in November 2024 and was appointed chair of the board in late 2025.
Vitura chair Robert Iervasi praised Fogarty for his “insight and dedication”.
A new chair of the advisory group, which was established to provide “expert-base guidance” to the board, will be announced “in due course”.